Unhealthy marketing of pharmaceutical products: An international public health concern

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

11 Citeringar (SciVal)

Sammanfattning

I consider the current state of pharmaceutical marketing vis-à-vis ethical and legal standards and advocate measures to improve it. There is abundant evidence of unethical or illicit marketing. It fuels growing concerns about undue corporate influence over pharmaceutical research, education, and consumption. The most extensive evidence of industry transgressions comes from the United States (US), where whistle-blowers are encouraged by financial rewards to help uncover illicit marketing and fraud. Outside the US increasing evidence of transgressions exists. Recently we have observed a range of new measures to align pharmaceutical marketing practices with ethical and legal standards. In the interest of public health, I highlight the need for additional and more profound reforms to ensure that information about medicines supports quality and resource-efficient care.
Originalspråkengelska
Sidor (från-till)149–159
TidskriftJournal of Public Health Policy
Volym37
Utgåva2
Tidigt onlinedatum2016 feb. 25
DOI
StatusPublished - 2016

Ämnesklassifikation (UKÄ)

  • Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi
  • Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi
  • Sociologi (exklusive socialt arbete, socialpsykologi och socialantropologi)

Fingeravtryck

Utforska forskningsämnen för ”Unhealthy marketing of pharmaceutical products: An international public health concern”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här